Novo Integrated Sciences, Inc. (NVOS)
NASDAQ: NVOS · IEX Real-Time Price · USD
0.120
-0.008 (-6.54%)
At close:
Mar 27, 2023, 4:00 PM
0.118
-0.002 (-1.83%)
After-hours:
Mar 27, 2023, 7:59 PM EDT
NVOS Market Cap
NVOS has a market cap or net worth of $17.31 million as of March 28, 2023. Its market cap has decreased by -78.97% in one year.
Market Cap
17.31M
Enterprise Value
25.46M
1-Year Change
-78.97%
Ranking
Category
Stock Price
$0.12
Market Cap Chart
Since August 29, 2011, Novo Integrated Sciences, Inc.'s market cap has increased from $7.96M to $17.31M, an increase of 117.60%. That is a compound annual growth rate of 6.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2023 | 17.31M | 352.14% |
| Mar 24, 2023 | 3.83M | 8.63% |
| Mar 23, 2023 | 3.52M | -4.45% |
| Mar 22, 2023 | 3.69M | -11.01% |
| Mar 21, 2023 | 4.14M | 37.08% |
| Mar 20, 2023 | 3.02M | 1.40% |
| Mar 17, 2023 | 2.98M | -13.42% |
| Mar 16, 2023 | 3.44M | -3.67% |
| Mar 15, 2023 | 3.58M | -3.85% |
| Mar 14, 2023 | 3.72M | -5.03% |
| Mar 13, 2023 | 3.92M | -7.54% |
| Mar 10, 2023 | 4.23M | -10.47% |
| Mar 9, 2023 | 4.73M | -17.87% |
| Mar 8, 2023 | 5.76M | -4.97% |
| Mar 7, 2023 | 6.06M | 16.78% |
| Mar 6, 2023 | 5.19M | 34.67% |
| Mar 3, 2023 | 3.85M | -3.22% |
| Mar 2, 2023 | 3.98M | 12.00% |
| Mar 1, 2023 | 3.55M | -5.92% |
| Feb 28, 2023 | 3.78M | 9.70% |
| Feb 27, 2023 | 3.44M | 3.22% |
| Feb 24, 2023 | 3.34M | -9.25% |
| Feb 23, 2023 | 3.68M | -3.82% |
| Feb 22, 2023 | 3.82M | -0.70% |
| Feb 21, 2023 | 3.85M | 0.94% |
View and export this data all the way back to 2011.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rain Therapeutics Inc. | 309.03M |
| Akebia Therapeutics, Inc. | 117.70M |
| Streamline Health Solutions, Inc. | 97.61M |
| Orchard Therapeutics plc | 90.34M |
| InflaRx N.V. | 79.57M |
| BioLineRx Ltd. | 48.65M |
| DiaMedica Therapeutics Inc. | 45.20M |
| Orgenesis Inc. | 39.04M |
| Bionomics Limited | 21.74M |
| Codiak BioSciences, Inc. | 16.21M |